top of page

SCLERODERMA, MORPHEA AND LYME DISEASE

Aug 3, 2024
5 min read

Updated: 2 days ago

I've been asked about scleroderma and Lyme disease more than once, so I dug into the research to share what I found. Lyme is known as "the great imitator," and the newest research suggests why it's worth ruling out when skin starts to harden.


Short on time or energy? A quick-view graphic with the key points is at the bottom of this post.


WHAT IS SCLERODERMA?


Scleroderma means "hard skin," but it isn't only a skin condition. It affects connective tissue, the tissue that holds the body together. There are two main types:


- Localized scleroderma, also called morphea, affects the skin and the tissue under it, and sometimes the muscle or bone beneath. It is the most common type. Linear scleroderma is a localized form, and the most common type in children. It causes lines of thicker skin, often on the limbs, trunk, forehead or scalp.

- Systemic scleroderma, also called systemic sclerosis, can reach beyond the skin to organs inside the body, including the heart, lungs, digestive tract, kidneys and blood vessels. It is usually more serious.


About 300,000 people in the United States have scleroderma: around 200,000 with the localized type and about 100,000 with the systemic type.


COMMON SIGNS


- Skin that becomes hard, tight, stiff or shiny, often on the hands and feet

- Hard, thickened patches or bands of skin

- Raynaud's (fingers or toes turning white or blue in the cold)

- Trouble swallowing, if the food pipe is involved

- Tiny calcium deposits under the skin, which can cause sores


Look up any of these symptoms in our Directory:


SCLERODERMA AND RAYNAUD'S


More than 9 in 10 people with scleroderma also have Raynaud's. The good news is that only a small number of people with Raynaud's go on to get scleroderma (on average, fewer than 2 in 100 women and fewer than 6 in 100 men). You can read more about Raynaud's here:


RAYNAUD'S AND CHILBLAINS IN LYME AND CO-INFECTIONS


HOW LYME DISEASE CAN PLAY A ROLE


Researchers have looked at a possible Lyme connection to scleroderma for years, mostly the localized type (morphea). Not every study agrees, but recent findings support checking for Lyme.


- A 2026 case report from Dartmouth described a 73-year-old woman with four years of painful, tingling, hardened skin patches on her feet and ankles, plus hard lumps over her spine, knees and elbow. She had trouble walking, and steroids gave her minimal benefit. She had no known history of Lyme. Her Lyme IgG test was positive (IgM was negative), and her ANA was positive. Testing found Lyme bacteria DNA right in the hardened skin, and it was the main Lyme species found in the U.S. (Borrelia burgdorferi sensu stricto). After 30 days of doxycycline, she had rapid, near-complete clearing of the patches, and her joint movement returned. The authors couldn't say for sure whether this was true morphea or a Lyme skin infection that looks like it. They stress the importance of early Lyme blood and skin tissue testing in people with skin-hardening conditions in areas where Lyme is common, which may help some people avoid immune-suppressing drugs. This is one patient, but it is a powerful example.


- A 2024 review explained that Lyme bacteria can interact with the immune system through molecular mimicry (when the immune system confuses the body's own tissue with the bacteria) and long-lasting infection. This may lead to symptoms resembling localized scleroderma, systemic sclerosis, lupus and dermatomyositis, though exactly how this happens isn't fully understood yet. Lyme and these autoimmune diseases can be mistaken for each other, which is why accurate testing matters so much.


- A 2020 Yale case report described a young man who developed morphea on his face in the same spot where Lyme had caused facial palsy twice before. The authors suggest Lyme may have led his immune system to start reacting against his own tissue in that area.


- A 2016 study of 32 hospital patients with localized scleroderma found that about 1 in 5 (18.8%) had Lyme antibodies at diagnostic levels, more than in the general population.


- A 2016 review reported that some studies found Lyme bacteria DNA in up to 33% of people with morphea, and Lyme bacteria seen on skin tissue slides in up to 69%. A link was mainly reported from Central Europe, Japan and South America, while other reports found no link, so results vary between studies and regions.


- A 2005 case report described a 61-year-old woman who already had Raynaud's and other early signs that put her at risk for systemic scleroderma. Her face and upper body suddenly swelled, and then her skin hardened in a way that looked like systemic scleroderma. Testing found Lyme, and she was treated with IV antibiotics. Two weeks after treatment ended, her skin had softened and looked normal again. The authors said Lyme should be considered in unusual cases of skin hardening in people who are at risk for systemic scleroderma.


ANA TESTING


Doctors often check for autoimmune conditions with blood tests such as the ANA (antinuclear antibody) test. A positive ANA on its own doesn't prove you have a disease, so it's one piece of the puzzle.


ANTINUCLEAR ANTIBODIES (ANA) IN LYME


WHEN TO TALK WITH YOUR DOCTOR


- New skin hardening, tightening or thick patches

- Raynaud's that starts for the first time after age 30, or comes with joint pain, rashes or muscle weakness

- Trouble swallowing

- Before starting immune-suppressing treatment, ask whether Lyme and co-infection testing makes sense for you, especially if you've lived in or visited an area where Lyme is common


RELATED POSTS


BULLSEYE AND OTHER RASHES IN LYME AND CO-INFECTIONS


Scleroderma, Morphea and Lyme Disease quick-view graphic

SOURCES

Diiorio et al. (Dartmouth), A complex case of chronic cutaneous Borrelia burgdorferi sensu stricto infection manifesting as morphea-like sclerosis in the United States, JAAD Case Reports (2026)

Doskaliuk and Zimba, Borrelia burgdorferi and autoimmune mechanisms: implications for mimicry, misdiagnosis, and mismanagement in Lyme disease and autoimmune disorders, Rheumatol Int (2024)

Xie, Cowper and Odell (Yale), Morphea after Borrelia-induced facial nerve palsy, J Scleroderma Relat Disord (2020/2021)

Zinchuk et al., Is Localized Scleroderma Caused by Borrelia burgdorferi?, Vector Borne Zoonotic Dis (2016, older source, still worth reading)

Aberer and Wutte, Atrophosclerodermic Manifestations of Lyme Borreliosis, Open Dermatol J (2016, older source, still worth reading)

Wackernagel, Bergmann and Aberer, Acute exacerbation of systemic scleroderma in Borrelia burgdorferi infection, J Eur Acad Dermatol Venereol (2005, older source, still worth reading)

Yale Medicine, Scleroderma (2024)

NHS, Raynaud's (2023)

Guy's and St Thomas' NHS Foundation Trust, Raynaud's syndrome and scleroderma (2026)

MedlinePlus, ANA (Antinuclear Antibody) Test (2025)


Disclaimer: Rise Above Lyme makes no claims about any possible benefit of using any product mentioned within this site. Always consult with your doctor before adding anything. The information shared is based on personal experience, years of accumulated researched resources from Lyme Literate doctors and polls conducted within Lyme groups from actual patient experience using these solution ideas.

Comments


bottom of page